Neulasta

Latest articles

12d
FOX Business
Amgen Wins Reprieve on Its 2nd-Best-Selling DrugThe "composition of matter" patent protecting Amgen Inc.'s (NASDAQ: AMGN) white
FOX Business / Posted 12 days ago
The "composition of matter" patent protecting Amgen Inc.'s (NASDAQ: AMGN) white-blood-cell-boosting drug Neulasta from competition has already expired. That may mean it's only a matter of time before generic drug companies, including Mylan(NASDAQ:... Read more
12d
FOX Business
Amgen Wins Reprieve on Its 2nd-Best-Selling DrugThe "composition of matter" patent protecting Amgen Inc.'s (NASDAQ: AMGN) white
FOX Business / Posted 12 days ago
The "composition of matter" patent protecting Amgen Inc.'s (NASDAQ: AMGN) white-blood-cell-boosting drug Neulasta from competition has already expired. That may mean it's only a matter of time before generic drug companies, including Mylan(NASDAQ:... Read more

In this news